STA
CVS icon

Summit Trail Advisors’s CVS Health CVS Stock Holding History

Summit Trail Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.83M Buy
53,374
+10,218
+24% +$787K 0.05% 226
2025
Q4 		$3.42M Sell
43,156
-6,580
-13% -$519K 0.06% 195
2025
Q3 		$3.75M Buy
49,736
+11,882
+31% +$814K 0.05% 190
2025
Q2 		$2.61M Buy
+37,854
New +$2.48M 0.04% 214
2024
Q4 		– Sell
-8,579
Closed -$539K – 479
2024
Q3 		$539K Sell
8,579
-5,703
-40% -$333K 0.01% 386
2024
Q2 		$843K Buy
14,282
+3,564
+33% +$223K 0.02% 266
2024
Q1 		$855K Buy
10,718
+2,332
+28% +$178K 0.02% 239
2023
Q4 		$662K Sell
8,386
-127
-1% -$9.04K 0.02% 234
2023
Q3 		$594K Sell
8,513
-124
-1% -$8.79K 0.02% 242
2023
Q2 		$597K Buy
8,637
+3,342
+63% +$238K 0.02% 233
2023
Q1 		$393K Buy
5,295
+1,239
+31% +$104K 0.02% 261
2022
Q4 		$378K Sell
4,056
-915
-18% -$88.3K 0.02% 233
2022
Q3 		$474K Buy
4,971
+1,143
+30% +$113K 0.03% 188
2022
Q2 		$355K Buy
3,828
+560
+17% +$54.7K 0.02% 241
2022
Q1 		$331K Sell
3,268
-202
-6% -$21.2K 0.03% 232
2021
Q4 		$358K Sell
3,470
-700
-17% -$64.7K 0.02% 204
2021
Q3 		$354K Buy
4,170
+454
+12% +$38K 0.03% 190
2021
Q2 		$310K Buy
3,716
+43
+1% +$3.52K 0.03% 171
2021
Q1 		$276K Buy
+3,673
New +$268K 0.03% 161
2018
Q1 		– Sell
-2,451
Closed -$194K – 726
2017
Q4 		$194K Buy
+2,451
New +$178K 0.02% 432

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Summit Trail Advisors's CVS Position: Q1 2026 in Review

Summit Trail Advisors increased its CVS Health (CVS) stake by 24% in Q1 2026, buying an estimated $787K and bringing the position to 53,374 shares worth $3.83M. The position accounts for 0.05% of the portfolio, ranked #226.

Summit Trail Advisors first reported a position in CVS in Q4 2017 and has held it in 20 quarters since. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Summit Trail Advisors held 53,374 shares of CVS Health worth $3.83M as of Q1 2026.
  • Summit Trail Advisors bought 10,218 CVS Health shares in Q1 2026, an estimated $787K.
  • CVS Health made up 0.05% of Summit Trail Advisors's portfolio in Q1 2026, its #226 holding.
  • Summit Trail Advisors first reported a position in CVS Health in Q4 2017 and has held it in 20 quarters since.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.